{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:24:40Z","timestamp":1784903080635,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroinflammation can accelerate neurodegeneration in Parkinson\u2019s disease (PD). This study aims to identify biomarkers related to PD inflammation and investigate the function of cardamonin (CD) on microglia and neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The differentially expressed genes (DEGs) in PD were screened out. Inflammation-related genes (IRGs) were obtained from the GSEA and GeneCards databases. The protein-protein interaction network was constructed, and three machine learning algorithms, least absolute shrinkage and selection operator (LASSO) regression analysis, random forest (RF) and support vector machine (SVM) were used to screen the core IRGs in PD pathogenesis. Potential drugs for core genes were screened through the ITCM and HERB databases, and the binding activity between the core targets and the drugs was verified by molecular docking. BV2 cells were induced with MPP\u2009+\u2009to construct a PD model. CCK-8 assay, flow cytometry, enzyme-linked immunosorbent assays, qPCR and western blotting were conducted to explore the function of CD on the activation of microglia and injury of neurons..<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One thousand one hundred eighty-three DEGs and 518 IRGs were obtained, and 31 genes were in the intersection, among which v-rel reticuloendotheliosis viral oncogene homolog A (RELA, p65), a crucial component in NF-\u03baB signaling, was upregulated in the PD samples and demonstrated good diagnostic efficacy. CD had good binding ability with RELA. CD significantly improved the viability, repressed apoptosis, reduced the production of pro-inflammatory factors (TNF-\u03b1, IL-6 and IL-1\u03b2) of BV2 cells, which were induced by MPP+. In addition, CD significantly inhibited the activation of the NF-\u03baB signaling pathway and the nuclear translocation of RELA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CD inhibits the inflammatory response of PD induced by microglia by targeting RELA and regulating the activation of NF-\u03baB signaling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00660-3","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:16:28Z","timestamp":1773044188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardamonin ameliorates neuroinflammation in Parkinson\u2019s disease by regulating NF-\u03baB signaling"],"prefix":"10.1186","volume":"163","author":[{"given":"Yezi","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"s2","key":"660_CR1","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.3233\/JPD-230411","volume":"14","author":"K Kulcsarova","year":"2024","unstructured":"Kulcsarova K, Skorvanek M, Postuma RB, Berg D. Defining Parkinson\u2019s Disease: Past and Future. J Parkinsons Dis. 2024;14(s2):S257\u201371.","journal-title":"J Parkinsons Dis"},{"key":"660_CR2","doi-asserted-by":"publisher","first-page":"102147","DOI":"10.1016\/j.arr.2023.102147","volume":"93","author":"J Burtscher","year":"2024","unstructured":"Burtscher J, Moraud EM, Malatesta D, Millet GP, Bally JF, Patoz A. Exercise and gait\/movement analyses in treatment and diagnosis of Parkinson\u2019s Disease. Ageing Res Rev. 2024;93:102147.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"660_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jcm15010063","volume":"15","author":"D Hern\u00e1ndez-Triana","year":"2025","unstructured":"Hern\u00e1ndez-Triana D, P\u00e1ez-Garc\u00eda S, Mena A, Gimeno M, Soto-Leal A, Rodriguez-Oroz MC, Borda MG. Parkinson\u2019s Disease and Frailty: A Two-Way Link Across Aging. J Clin Med. 2025;15(1):63.","journal-title":"J Clin Med"},{"issue":"1","key":"660_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020;36(1):1\u201312.","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"660_CR5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.5664\/jcsm.10450","volume":"19","author":"A Scanga","year":"2023","unstructured":"Scanga A, Lafontaine AL, Kaminska M. An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson\u2019s disease. J Clin Sleep Med. 2023;19(6):1133\u201344.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"660_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13205-025-04681-z","volume":"16","author":"I Bano","year":"2026","unstructured":"Bano I, Jeevanandam J, Tsenov G. Advances in therapeutic hybrid neuromodulation for Parkinson\u2019s disease. 3 Biotech. 2026;16(1):58.","journal-title":"3 Biotech"},{"issue":"1","key":"660_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s12276-023-01144-4","volume":"56","author":"TR Kee","year":"2024","unstructured":"Kee TR, Khan SA, Neidhart MB, Masters BM, Zhao VK, Kim YK, McGill Percy KC, Woo JA. The multifaceted functions of \u03b2-arrestins and their therapeutic potential in neurodegenerative diseases. Exp Mol Med. 2024;56(1):129\u201341.","journal-title":"Exp Mol Med"},{"issue":"1","key":"660_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.36518\/2689-0216.1718","volume":"6","author":"R Cromwell","year":"2025","unstructured":"Cromwell R, Um T. The Wearing Off Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson\u2019s Disease. HCA Healthc J Med. 2025;6(1):71\u20134.","journal-title":"HCA Healthc J Med"},{"key":"660_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2026.01.001","volume":"88","author":"R Dhapola","year":"2026","unstructured":"Dhapola R, Kumari S, Sharma P, Paidlewar M, Vellingiri B, Medhi B, HariKrishnaReddy D. Cytokine associated neuroinflammation in Parkinson\u2019s disease: Molecular pathways, therapeutic targets, and translational insights. Cytokine Growth Factor Rev. 2026;88:1\u201317.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"660_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(25)00382-5","volume":"25","author":"M de Castro Fonseca","year":"2026","unstructured":"de Castro Fonseca M, Zanetti L, Fanourakis S, Sulzer DL, Mazmanian SK. The gut microbiome, systemic inflammation, and autoimmunity in Parkinson\u2019s disease. Lancet Neurol. 2026;25(1):103\u201314.","journal-title":"Lancet Neurol"},{"issue":"7","key":"660_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T. Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells. 2023;12(7):1012.","journal-title":"Cells"},{"issue":"22","key":"660_CR12","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.3390\/ijms21228421","volume":"21","author":"C Marogianni","year":"2020","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G. Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson\u2019s Disease. Int J Mol Sci. 2020;21(22):8421.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"660_CR13","doi-asserted-by":"publisher","first-page":"110911","DOI":"10.5306\/wjco.v16.i11.110911","volume":"16","author":"NA Badroon","year":"2025","unstructured":"Badroon NA, Alsalahi A, Aljaberi MA, Abdul Majid N, Alshawsh MA. Cardamonin as a potential anticancer agent: Preclinical insights and clinical implications. World J Clin Oncol. 2025;16(11):110911.","journal-title":"World J Clin Oncol"},{"key":"660_CR14","doi-asserted-by":"publisher","first-page":"118601","DOI":"10.1016\/j.lfs.2020.118601","volume":"263","author":"C Bailly","year":"2020","unstructured":"Bailly C, Vergoten G. Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis. Life Sci. 2020;263:118601.","journal-title":"Life Sci"},{"issue":"5","key":"660_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/biom11050661","volume":"11","author":"S James","year":"2021","unstructured":"James S, Aparna JS, Babu A, Paul AM, Lankadasari MB, Athira SR, Kumar SS, Vijayan Y, Namitha NN, Mohammed S, Reshmi G, Harikumar KB. Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer. Biomolecules. 2021;11(5):661.","journal-title":"Biomolecules"},{"issue":"4","key":"660_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/ptr.7409","volume":"36","author":"H Ni","year":"2022","unstructured":"Ni H, Li J, Zheng J, Zhou B. Cardamonin attenuates cerebral ischemia\/reperfusion injury by activating the HIF-1\u03b1\/VEGFA pathway. Phytother Res. 2022;36(4):1736\u201347.","journal-title":"Phytother Res"},{"issue":"3","key":"660_CR17","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s11030-020-10155-6","volume":"25","author":"L Crisan","year":"2021","unstructured":"Crisan L, Istrate D, Bora A, Pacureanu L. Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson\u2019s disease treatment. Mol Diversity. 2021;25(3):1775\u201394.","journal-title":"Mol Diversity"},{"key":"660_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/1471-2105-13-335","volume":"13","author":"J Taminau","year":"2012","unstructured":"Taminau J, Meganck S, Lazar C, Steenhoff D, Coletta A, Molter C, Duque R, de Schaetzen V, Weiss Sol\u00eds DY, Bersini H, Now\u00e9 A. Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R\/Bioconductor packages. BMC Bioinformatics. 2012;13:335.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"660_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"issue":"W1","key":"660_CR20","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"36","key":"660_CR21","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1021\/acs.jafc.3c01880","volume":"71","author":"B Zhang","year":"2023","unstructured":"Zhang B, Chen ZY, Jiang Z, Huang S, Liu XH, Wang L. Nephroprotective Effects of Cardamonin on Renal Ischemia Reperfusion Injury\/UUO-Induced Renal Fibrosis. J Agric Food Chem. 2023;71(36):13284\u2013303.","journal-title":"J Agric Food Chem"},{"key":"660_CR22","doi-asserted-by":"publisher","first-page":"1657349","DOI":"10.3389\/fnagi.2025.1657349","volume":"17","author":"YJ Chen","year":"2025","unstructured":"Chen YJ, Xie MR, Zhou SQ, Liu F. Microglia-associated research in Parkinson\u2019s disease: a bibliometric analysis. Front Aging Neurosci. 2025;17:1657349.","journal-title":"Front Aging Neurosci"},{"key":"660_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.mcb.2025.02.006","volume":"197","author":"JA Morales-Garc\u00eda","year":"2025","unstructured":"Morales-Garc\u00eda JA. Modeling neurodegeneration and neuroinflammation in Parkinson\u2019s Disease: Animal-based strategies. Methods Cell Biol. 2025;197:81\u2013114.","journal-title":"Methods Cell Biol"},{"issue":"4","key":"660_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","volume":"141","author":"AS Harms","year":"2021","unstructured":"Harms AS, Ferreira SA, Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease. Acta Neuropathol. 2021;141(4):527\u201345.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"660_CR25","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, Amara AW, Standaert DG, Goldman JG, Litvan I, Peters B, Sulzer D, Sette A. \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun. 2020;11(1):1875.","journal-title":"Nat Commun"},{"issue":"7660","key":"660_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"issue":"7","key":"660_CR27","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain. 2021;144(7):2047\u201359.","journal-title":"Brain"},{"key":"660_CR28","doi-asserted-by":"publisher","first-page":"855776","DOI":"10.3389\/fnagi.2022.855776","volume":"14","author":"M Fathi","year":"2022","unstructured":"Fathi M, Vakili K, Yaghoobpoor S, Qadirifard MS, Kosari M, Naghsh N, Asgari Taei A, Klegeris A, Dehghani M, Bahrami A, Taheri H, Mohamadkhani A, Hajibeygi R, Rezaei Tavirani M, Sayehmiri F. Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson\u2019s Disease: A Systematic Review. Front Aging Neurosci. 2022;14:855776.","journal-title":"Front Aging Neurosci"},{"key":"660_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.taap.2018.09.003","volume":"358","author":"GU Hong","year":"2018","unstructured":"Hong GU, Cho JW, Kim SY, Shin JH, Ro JY. Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson\u2019s disease in a mouse model. Toxicol Appl Pharmacol. 2018;358:10\u201322.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"660_CR30","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s11064-015-1790-z","volume":"41","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj D, Thangavel R, Fattal R, Pattani S, Yang E, Zaheer S, Santillan DA, Santillan MK, Zaheer A. Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+)). Neurochem Res. 2016;41(5):1042\u20139.","journal-title":"Neurochem Res"},{"key":"660_CR31","doi-asserted-by":"publisher","first-page":"578154","DOI":"10.1016\/j.jneuroim.2023.578154","volume":"382","author":"J Holbrook","year":"2023","unstructured":"Holbrook J, Patel B, Camacho M, Kahanawita L, Greenland J, Williams-Gray CH. Natural killer cells have an activated profile in early Parkinson\u2019s disease. J Neuroimmunol. 2023;382:578154.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"660_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41531-021-00271-x","volume":"8","author":"J Tian","year":"2022","unstructured":"Tian J, Dai SB, Jiang SS, Yang WY, Yan YQ, Lin ZH, Dong JX, Liu Y, Zheng R, Chen Y, Zhang BR, Pu JL. Specific immune status in Parkinson\u2019s disease at different ages of onset. NPJ Parkinsons Dis. 2022;8(1):5.","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"660_CR33","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s12276-020-00505-7","volume":"52","author":"RH Earls","year":"2020","unstructured":"Earls RH, Lee JK. The role of natural killer cells in Parkinson\u2019s disease. Exp Mol Med. 2020;52(9):1517\u201325.","journal-title":"Exp Mol Med"},{"key":"660_CR34","doi-asserted-by":"publisher","first-page":"890816","DOI":"10.3389\/fnagi.2022.890816","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Y, Fan D. Pathological Role of Natural Killer Cells in Parkinson\u2019s Disease: A Systematic Review. Front Aging Neurosci. 2022;14:890816.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"660_CR35","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","volume":"11","author":"S Garofalo","year":"2020","unstructured":"Garofalo S, Cocozza G, Porzia A, Inghilleri M, Raspa M, Scavizzi F, Aronica E, Bernardini G, Peng L, Ransohoff RM, Santoni A, Limatola C. Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis. Nat Commun. 2020;11(1):1773.","journal-title":"Nat Commun"},{"issue":"9","key":"660_CR36","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1084\/jem.20092749","volume":"207","author":"J Hao","year":"2010","unstructured":"Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI, Xiang R, La Cava A, Van Kaer L, Shi FD. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med. 2010;207(9):1907\u201321.","journal-title":"J Exp Med"},{"issue":"14","key":"660_CR37","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1016\/j.cell.2024.05.030","volume":"187","author":"TW Kim","year":"2024","unstructured":"Kim TW, Koo SY, Riessland M, Chaudhry F, Kolisnyk B, Cho HS, Russo MV, Saurat N, Mehta S, Garippa R, Betel D, Studer L. TNF-NF-\u03baB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons. Cell. 2024;187(14):3671\u2013e368923.","journal-title":"Cell"},{"issue":"6","key":"660_CR38","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/ijms26062505","volume":"26","author":"MY Zheng","year":"2025","unstructured":"Zheng MY, Luo LZ. The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases. Int J Mol Sci. 2025;26(6):2505.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"660_CR39","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.7150\/jca.73690","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu L, Lu J, Xie H, Ni J, Chen S, Zhao Q, Xie N, Lu L, Wang X, Li B. RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24. J Cancer. 2022;13(9):2781\u201397.","journal-title":"J Cancer"},{"issue":"8","key":"660_CR40","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1007\/s00125-023-05931-6","volume":"66","author":"NW Zammit","year":"2023","unstructured":"Zammit NW, Wong YY, Walters SN, Warren J, Barry SC, Grey ST. RELA governs a network of islet-specific metabolic genes necessary for beta cell function. Diabetologia. 2023;66(8):1516\u201331.","journal-title":"Diabetologia"},{"key":"660_CR41","doi-asserted-by":"publisher","first-page":"719807","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, Xiong N, Wang T. Targeting Microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s Disease. Front Immunol. 2021;12:719807.","journal-title":"Front Immunol"},{"issue":"40","key":"660_CR42","doi-asserted-by":"publisher","first-page":"eadi8343","DOI":"10.1126\/sciadv.adi8343","volume":"9","author":"J Wu","year":"2023","unstructured":"Wu J, Han Y, Xu H, Sun H, Wang R, Ren H, Wang G. Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the p300\/NF-\u03baB\/NLRP3 pathway. Sci Adv. 2023;9(40):eadi8343.","journal-title":"Sci Adv"},{"key":"660_CR43","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.2147\/IJN.S459510","volume":"19","author":"L Lin","year":"2024","unstructured":"Lin L, Liu Y, Tang R, Ding S, Lin H, Li H. Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa. Int J Nanomed. 2024;19:9843\u201370.","journal-title":"Int J Nanomed"},{"issue":"3","key":"660_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11571-017-9471-z","volume":"12","author":"D Wang","year":"2018","unstructured":"Wang D, Wang C, Liu L, Li S. Protective effects of evodiamine in experimental paradigm of Alzheimer\u2019s disease. Cogn Neurodyn. 2018;12(3):303\u201313.","journal-title":"Cogn Neurodyn"},{"issue":"5","key":"660_CR45","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/ijms19051527","volume":"19","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang J, Wang C, Li Z, Liu X, Zhang J, Lu J, Wang D. Pharmacological Basis for the Use of Evodiamine in Alzheimer\u2019s Disease: Antioxidation and Antiapoptosis. Int J Mol Sci. 2018;19(5):1527.","journal-title":"Int J Mol Sci"},{"key":"660_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopha.2017.12.017","volume":"98","author":"YN Zhang","year":"2018","unstructured":"Zhang YN, Yang YF, Yang XW. Blood-brain barrier permeability and neuroprotective effects of three main alkaloids from the fruits of Euodia rutaecarpa with MDCK-pHaMDR cell monolayer and PC12 cell line. Biomed Pharmacother. 2018;98:82\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"660_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10571-020-00839-w","volume":"41","author":"T Meng","year":"2021","unstructured":"Meng T, Fu S, He D, Hu G, Gao X, Zhang Y, Huang B, Du J, Zhou A, Su Y, Liu D. Evodiamine Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in BV-2 Cells via Regulating AKT\/Nrf2-HO-1\/NF-\u03baB Signaling Axis. Cell Mol Neurobiol. 2021;41(1):115\u201327.","journal-title":"Cell Mol Neurobiol"},{"issue":"13","key":"660_CR48","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.3390\/ijms241310872","volume":"24","author":"K Barber","year":"2023","unstructured":"Barber K, Mendonca P, Evans JA, Soliman KFA. Antioxidant and Anti-Inflammatory Mechanisms of Cardamonin through Nrf2 Activation and NF-kB Suppression in LPS-Activated BV-2 Microglial Cells. Int J Mol Sci. 2023;24(13):10872.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"660_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/brainsci13010145","volume":"13","author":"K Barber","year":"2023","unstructured":"Barber K, Mendonca P, Soliman KFA. The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer\u2019s Disease. Brain Sci. 2023;13(1):145.","journal-title":"Brain Sci"},{"key":"660_CR50","doi-asserted-by":"publisher","first-page":"e15498","DOI":"10.7717\/peerj.15498","volume":"11","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang S, Niu P, Chen H, Zhou J, Jiang L, Li D, Shi D. Raptor couples mTORC1 and ERK1\/2 inhibition by cardamonin with oxidative stress induction in ovarian cancer cells. PeerJ. 2023;11:e15498.","journal-title":"PeerJ"},{"issue":"1","key":"660_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13046-019-1351-4","volume":"38","author":"J Jin","year":"2019","unstructured":"Jin J, Qiu S, Wang P, Liang X, Huang F, Wu H, Zhang B, Zhang W, Tian X, Xu R, Shi H, Wu X. Cardamonin inhibits breast cancer growth by repressing HIF-1\u03b1-dependent metabolic reprogramming. J Exp Clin Cancer Res. 2019;38(1):377.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"660_CR52","doi-asserted-by":"publisher","first-page":"20802","DOI":"10.1038\/s41598-024-71817-1","volume":"14","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wang Y, Liu H, Hu Q, Xie Y, Nan X, He H, Liu Y. Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K\/AKT signaling pathway. Sci Rep. 2024;14(1):20802.","journal-title":"Sci Rep"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00660-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:37:04Z","timestamp":1781638624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00660-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["660"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00660-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript, and agreed to publish this article in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}